Pilot and evaluation of a general practice led intervention to optimise National Bowel Cancer Screening Program participation.

niversity of Sydney0 个研究点目标入组 100 人开始时间: 2023年4月5日最近更新: 2023年10月23日

试验速览

暂无简介。

•General Practices inclusion criteria:
•Has at least two GPs (FTE) willing to participate in the trial
•Nominated Practice Champion who is willing and able to liaise with the Daffodil Centre research team
•Uses Medical Director or Best Practice software
•Uses Pen CS, Polar or Primary Sense
•Available over the trial period May 2023 – June 2023
•Windows 10 or higher, i5/i7 16GB processing or willing to upgrade
•Has over 1000 active patients and sees minimum of 35 adult patients per day
•Adult patient inclusion criteria:
•Inclusion criteria
•General Practice patients aged 50 to 74 years

•General Practice exclusion criteria:
•Shares server with another practice
•Uses paper-based medical records
•Does not share data with PHN
•Adult patient exclusion criteria:
•Exclusion criteria
•Under 50 or over 74 years
•Previous or current diagnosis of CRC
•Previous or current diagnosis of inflammatory bowel disease – e.g., ulcerative colitis or Chron’s disease
•Familial syndrome associated with increased risk of CRC: lynch syndrome, familial adenomatous polyposis (FAP), attenuated FAP (AFAP), MUTYH-associated polyposis, polymerase proof-reading associated polyposis (PPAP), NTHL1-associated polyposis (NAP), Peutz-Jeghers syndrome, Juvenile polyposis syndrome, Serrated polyposis syndrome, and Cowden syndrome

发起方